ALAM
VRTX icon

Asahi Life Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Asahi Life Asset Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,280
Closed -$515K – 222
2024
Q4 		$515K Buy
+1,280
New +$593K 0.31% 60
2024
Q2 		– Sell
-560
Closed -$234K – 221
2024
Q1 		$234K Buy
+560
New +$237K 0.14% 162
2023
Q4 		– Sell
-555
Closed -$193K – 243
2023
Q3 		$193K Sell
555
-885
-61% -$310K 0.07% 170
2023
Q2 		$507K Sell
1,440
-65
-4% -$21.9K 0.17% 63
2023
Q1 		$474K Buy
+1,505
New +$451K 0.15% 75
2022
Q3 		– Sell
-1,455
Closed -$410K – 309
2022
Q2 		$410K Sell
1,455
-285
-16% -$76.3K 0.11% 76
2022
Q1 		$454K Sell
1,740
-895
-34% -$212K 0.06% 106
2021
Q4 		$579K Buy
2,635
+150
+6% +$29.2K 0.07% 75
2021
Q3 		$451K Sell
2,485
-80
-3% -$15.6K 0.06% 89
2021
Q2 		$517K Buy
2,565
+400
+18% +$83.7K 0.07% 78
2021
Q1 		$465K Sell
2,165
-350
-14% -$76.9K 0.06% 104
2020
Q4 		$594K Buy
2,515
+475
+23% +$109K 0.08% 87
2020
Q3 		$555K Buy
+2,040
New +$563K 0.08% 65
2019
Q4 		– Sell
-1,600
Closed -$271K – 276
2019
Q3 		$271K Buy
+1,600
New +$283K 0.04% 142
2019
Q1 		– Sell
-3,550
Closed -$588K – 230
2018
Q4 		$588K Buy
+3,550
New +$615K 0.09% 61

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Asahi Life Asset Management's VRTX Position: Q1 2025 in Review

Asahi Life Asset Management sold out of Vertex Pharmaceuticals (VRTX) in Q1 2025, closing a stake of 1,280 shares — an estimated $515K sold.

Asahi Life Asset Management first reported a position in VRTX in Q4 2018 and held it in 15 quarters. The position peaked at $594K in Q4 2020. 1,613 funds tracked by Wall St. Rank hold VRTX as of Q1 2025.

  • Asahi Life Asset Management reported no remaining Vertex Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Asahi Life Asset Management sold 1,280 Vertex Pharmaceuticals shares in Q1 2025, an estimated $515K.
  • Asahi Life Asset Management first reported a position in Vertex Pharmaceuticals in Q4 2018 and held it in 15 quarters.
  • Asahi Life Asset Management's Vertex Pharmaceuticals position peaked at $594K in Q4 2020.
  • 1,613 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2025.

Based on Asahi Life Asset Management's 13F filing for Q1 2025, filed 2 May 2025.